AVALO THERAPEUTICS, INC. Gain (Loss) on Disposition of Assets
AVALO THERAPEUTICS, INC. (AVTX) reported Gain (Loss) on Disposition of Assets of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-14.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2017-03-14
- AVALO THERAPEUTICS, INC. gain (loss) on disposition of assets for fiscal 2016 was $0.00.
- AVALO THERAPEUTICS, INC. gain (loss) on disposition of assets for fiscal 2015 was $0.00.
- AVALO THERAPEUTICS, INC. gain (loss) on disposition of assets for fiscal 2014 was -$17.81K.
| Period end | Gain (Loss) on Disposition of Assets 12 month | Gain (Loss) on Disposition of Assets 12 month as first filed |
|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-14 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-14 | |
| 2014-12-31 | -$17.81K 10-K · filed 2017-03-14 | $17.81K 10-K · filed 2016-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |